心脏衰竭随着轻微减少的喷射分数:呼吁采用精确医学方法
Lingling Wu1, Affan Rizwan2, Mario Rodriguez3
1Cardiovascular Division, University of Alabama at Birmingham, Birmingham, Alabama, USA.
JACC. Advances
|January 29, 2026
概括
轻微减少喷射分数 (HFmrEF) 的心力衰竭是一种复杂的疾病. 精准医学整合先进的诊断和基因组学提供了一条有前途的途径,以改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 医学诊断 医学诊断 医学诊断
- 基因组学就是基因组学.
背景情况:
- 轻微减少喷射分数 (HFmrEF) 的心力衰竭是一种公认的,但异质的心力衰竭表型.
- 通过新的诊断工具和分子分析,了解HFmrEF病理生理学已经取得了进展.
研究的目的:
- 探索HFmrEF不断变化的理解和管理策略.
- 突出精准医学在解决HFmrEF异质性的潜力.
主要方法:
- 检查诊断工具的进步:压力成像,心脏MRI,分子成像.
- 整合基因组学和生物标志物分析,以获得更深入的病理生理学洞察力.
- 对最近的研究和治疗选择的子组数据的分析.
主要成果:
- 诊断和分子方面的进步改善了对HFmrEF的理解.
- 有限的直接临床证据存在,但有前途的治疗方案正在出现.
- 在HFmrEF内部显著的异质性需要个性化的治疗方法.
结论:
- 未来的HFmrEF管理应该优先考虑精准医学和量身定制的护理.
- 整合先进的成像,生物标志物和基因组学对于优化结果至关重要.
- 基于精度的方法可以重新定义护理,并改善HFmrEF患者的预后.
相关概念视频
Heart Failure II: Pathophysiology
907
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
907
Pathophysiology of Heart Failure
3.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.6K
Heart Failure I: Introduction
877
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
877
Heart Failure VI: Adjunct Therapies
332
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
332
Heart Failure Drugs: Diuretics
963
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
963
Heart Failure V: Medical Management
308
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
308


